about the author

Chi-Hsin Richard King, Ph.D.

Dr. King brings an unparalleled depth of knowledge and expertise to the biotechnology research and development field, boasting a remarkable career spanning over four decades. His profound understanding and specialization in discovering and developing novel drugs set him apart as a luminary in the scientific community. Dr. King’s journey through the intricate landscape of biotechnology has seen him play pivotal roles in a wide array of projects. His work encompasses the entire spectrum of drug development, from the initial identification of viable in vitro candidates to the meticulous process of submitting Investigational New Drug (IND) applications and managing the complexities of Phase I, II, and III clinical trials across multiple nations and centers.

about the Book

Brief description

The narrative chronicled in the book offers a comprehensive account of the journey of Nemonoxacin, tracing its evolution from its inception as a novel chemical entity to its successful commercial launch in various formulations. Nemonoxacin debuted in the pharmaceutical market as Taigexyn® Capsule, a 250 mg oral dosage form, approved in Taiwan in 2014 and subsequently in China in 2016. It further expanded its presence with the introduction of Taigenxyn® Intravenous Injection, a 500 mg/250 mL preparation for parenteral administration, which gained approval in Taiwan (2020), China (2021), and Russia (2022).

Our Best Sellers

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Original price was: $500.00.Current price is: $84.97.
Original price was: $500.00.Current price is: $84.97.
Original price was: $500.00.Current price is: $84.97.
Original price was: $500.00.Current price is: $84.97.

My Blogs

News & Articles

Reviews